Cargo Therapeutics Inc 's

• CRGX's Stock Performance relative to its Competitors

Taysha Gene Therapies Inc Share Performance -18.58% This Quarter

Taysha Gene Therapies Inc Profile Taysha Gene Therapies Inc operates under a business model focused on developing and commercializing innovative genetic therapies to treat and potentially cure patients with rare monogenic diseases. Utilizing cutting-edge technologies, the company aims to bring transformative treatments to market in order to improve the lives of individuals suffering from these rare genetic disorders. More about Taysha Gene Therapies Inc 's Market Share

4d Molecular Therapeutics Inc Share Performance +61.78% This Quarter

4d Molecular Therapeutics Inc Profile 4D Molecular Therapeutics Inc operates with a business model focused on developing innovative gene therapy products to address serious genetic diseases. The company utilizes its proprietary technology platform to design and optimize viral vectors for targeted gene delivery. With a strong commitment to research and development, 4D Molecular Therapeutics collaborates with partners in academia, industry, and patient organizations to advance transformative treatments for patients in need. More about 4d Molecular Therapeutics Inc 's Market Share

Editas Medicine Inc Share Performance +10.98% This Quarter

Editas Medicine Inc Profile Editas Medicine Inc.'s business model revolves around developing and commercializing transformative genome editing technologies to treat serious diseases. More about Editas Medicine Inc 's Market Share

Precision Biosciences Inc Share Performance -3.79% Over The Past 5 Days

Precision Biosciences Inc Profile Precision Biosciences Inc operates under a business model focused on gene editing. They develop and commercialize its ARCUS genome editing platform to create innovative therapies for genetic diseases and cancer. The company offers its gene editing capabilities to partners and collaborates on various research and development projects. More about Precision Biosciences Inc's Market Share

Ginkgo Bioworks Holdings Inc Share Performance -33.67% One Year

Ginkgo Bioworks Holdings Inc Profile Ginkgo Bioworks Holdings Inc is a biotechnology company that focuses on using genetic engineering to develop new organisms for various industries. Their business model includes partnering with companies to create custom-designed organisms for applications such as fragrance production, food and beverage, agriculture, and pharmaceuticals. They generate revenue through collaborations, licensing agreements, and providing access to their platform for organism design and development. More about Ginkgo Bioworks Holdings Inc 's Market Share

Sources: Cargo Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 18, 2026 6:01 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cargo Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.